CytoVeris Patents – Insights & Stats (Updated 2023)

CytoVeris has a total of 31 patents globally, out of which 4 have been granted. Of these 31 patents, more than 74% patents are active. The United States of America is where CytoVeris has filed the maximum number of patents, followed by Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of CytoVeris.

CytoVeris was founded in 2018. CytoVeris offers instruments for cancer surgery. During operation, the company helps cancer doctors distinguish between healthy and cancerous tissue in real time.

Do read about some of the most popular patents of CytoVeris which have been covered by us in this article and also you can find CytoVeris patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over CytoVeris patent portfolio.

How many patents do the Founder and CEO of CytoVeris have?

The Founder and CEO Alan Kersey have 47 patents.

How many patents does CytoVeris have?

CytoVeris has a total of 31 patents globally. These patents belong to 21 unique patent families. Out of 31 patents, 23 patents are active.

How Many Patents did CytoVeris File Every Year?

CytoVeris Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCytoVeris Applications FiledCytoVeris Patents Granted
202322
202271
2021141
20208

How many CytoVeris patents are Alive/Dead?

Worldwide Patents

CytoVeris Patent Portfolio

How Many Patents did CytoVeris File in Different Countries?

CytoVeris Worldwide Patent Filing

Countries in which CytoVeris Filed Patents

CountryPatent
United States of America17
Europe4

List of CytoVeris patents

CytoVeris PatentsTitle
US11725984B2Raman Spectroscopy-Based Optical Matched Filter System And Method For Using The Same
US11686684B2Raman Spectroscopy Based Assay For Both Low And High Abundant Biomolecules In A Biological Fluid Sample
US11441949B2Method And Apparatus For Identifying A Raman Spectrum From Background Fluorescence
US11193827B2Method And Apparatus For Identifying Background Fluorescence Using Spread Spectrum Excitation-Source Broadening In Raman Spectroscopy
US20230324300A1Autofluorescence-Based Biomolecular Barcode Approach For Tissue Classification
US20230296519A1Autofluorescence-Based Targeting Of Pathologically/Diagnostically Relevant Tissue Regions For Efficient And Accurate Omics Profiling
US20230266170A1Spectrometer-Less Sample Analysis System And Method Using High Wavenumber Raman Scattering
US20230162410A1Multi-Spectral Auto-Fluorescence Based Stainless And Slide-Free Virtual Histology
US20220317046A1Digital Mirror Device Based Code-Division Multiplexed Raman Optical Mapping System For Wide Field Imaging
US20220284603A1System And Method For Producing An Image-Based Registration Of Surgically Excised Tissue Specimens
US20220283092A1Method And System For Identifying Tissue Type Based On Peak-Fitted Parameters In High-Wavenumber Raman Spectrum
US20220283093A1System And Method For Classification Of Tissue Based On Raman And Fluorescence In High-Wavenumber Raman Spectrum
US20220196557A1Angular Depth Resolved Raman Spectroscopy Apparatus And Method
US20220099580A1Method And System For Detecting Cancerous Tissue And Tumor Margin Using Raman Spectroscopy
US20220079450A1Method And Probe System For Tissue Analysis In A Surgical Cavity In An Intraoperative Procedure
US20220065791A1Stimulated Raman Spectroscopy Based Multiplexed Virtual Immunohistology Using Alkynic, Nitrile, Or Azide Probes
US20210325302A1Determination Of Margin In Freshly Resected Tissue Specimens Using Tumor Responsive Tissue Marking Dye
EP4214487A1Multi-Spectral Imager For Uv-Excited Tissue Autofluorescence Mapping
EP4185859A1Spectrometer-Less Sample Analysis System And Method Using High Wavenumber Raman Scattering
EP4097455A1Apparatus And Method For Detecting And Treating Cancerous Tissue Using Raman Spectroscopy And Hyperthermia
EP3917382A4Method And System For Detecting Cancerous Tissue And Tumor Margin Using Raman Spectroscopy
WO2023278673A1Method And Apparatus For Mitigating Specular Highlights In Imaging Of Biological Tissue
WO2022261106A1A Smart Tissue Classification Framework Based On Multi-Classifier Systems
WO2022150408A1Multi-Modal Multi-Spectral Imaging System And Method For Characterizing Tissue Types In Bladder Specimens
WO2022061186A1Multi-Spectral Imager For Uv-Excited Tissue Autofluorescence Mapping
WO2022020807A1Spectrometer-Less Sample Analysis System And Method Using High Wavenumber Raman Scattering
WO2021216740A1Uv Excited Multi Spectral Fluorescence Based Tissue Analysis With Raman Spectroscopy Zoom-In Scanning
WO2021155375A1Apparatus And Method For Detecting And Treating Cancerous Tissue Using Raman Spectroscopy And Hyperthermia
WO2021011823A1Digital Mirror Device Based Code-Division Multiplexed Raman Optical Mapping System For Wide Field Imaging
WO2020206420A1Angular Depth Resolved Raman Spectroscopy Apparatus And Method
WO2020160462A1Method And System For Detecting Cancerous Tissue And Tumor Margin Using Raman Spectroscopy

What are CytoVeris key innovation segments?

What Technologies are Covered by CytoVeris?

The chart below distributes patents filed by CytoVeris in different countries on the basis of the technology protected in patents. It also represents the markets where CytoVeris thinks it’s important to protect particular technology inventions.

R&D Focus: How has CytoVeris search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by CytoVeris?

Related Articles

Arashi Vision Patents – Insights & Stats (Updated 2024)

Arashi Vision has a total of 1257 patents globally, out of which 751 have been granted. Of these 1257 patents, more than 87% patents are active. China is where Arashi Vision has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems

Read More »

Terecircuits Patents – Insights & Stats (Updated 2024)

Terecircuits has a total of 43 patents globally, out of which 22 have been granted. Of these 43 patents, more than 37% patents are active. United States of America is where Terecircuits has filed the maximum number of patents, followed by Europe (EPO) and Taiwan. Parallelly, United States of America

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.